These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 16099033

  • 21. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
    Kenne E, Nickel KF, Long AT, Fuchs TA, Stavrou EX, Stahl FR, Renné T.
    J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
    [Abstract] [Full Text] [Related]

  • 22. [Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process].
    He S, Xiong S, He R, He X, Liu F, Han J, Li J.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):118-21. PubMed ID: 11876967
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A, Suzuki Y, Sugihara K, Kanayama N, Urano T.
    Life Sci; 2009 Jul 31; 85(5-6):220-5. PubMed ID: 19500599
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. FXII contact activation products have an inhibitory effect on αFXIIa.
    Xu LC, Siedlecki CA.
    J Biomed Mater Res A; 2024 Aug 31; 112(8):1213-1223. PubMed ID: 37737653
    [Abstract] [Full Text] [Related]

  • 30. Factor XII truncation accelerates activation in solution.
    de Maat S, Clark CC, Boertien M, Parr N, Sanrattana W, Hofman ZLM, Maas C.
    J Thromb Haemost; 2019 Jan 31; 17(1):183-194. PubMed ID: 30394658
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
    Ivanov I, Matafonov A, Sun MF, Cheng Q, Dickeson SK, Verhamme IM, Emsley J, Gailani D.
    Blood; 2017 Mar 16; 129(11):1527-1537. PubMed ID: 28069606
    [Abstract] [Full Text] [Related]

  • 35. Moderation of prekallkrein-factor XII interactions in surface activation of coagulation by protein-adsorption competition.
    Chatterjee K, Thornton JL, Bauer JW, Vogler EA, Siedlecki CA.
    Biomaterials; 2009 Oct 16; 30(28):4915-20. PubMed ID: 19552950
    [Abstract] [Full Text] [Related]

  • 36. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
    Hu Y, Wang H, Jiao J, Wang Y, Yu W, Ling X.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep 16; 21(9):466-8. PubMed ID: 11877020
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
    Truong TK, Malik RA, Yao X, Fredenburgh JC, Stafford AR, Madarati HM, Kretz CA, Weitz JI.
    J Thromb Haemost; 2022 Apr 16; 20(4):821-832. PubMed ID: 34967109
    [Abstract] [Full Text] [Related]

  • 40. Fibrinolytic properties of activated FXII.
    Braat EA, Dooijewaard G, Rijken DC.
    Eur J Biochem; 1999 Aug 16; 263(3):904-11. PubMed ID: 10469157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.